Bypass Replication of the Cisplatin-d(GpG) Lesion by Calf Thymus DNA Polymerase β and Human Immunodeficiency Virus Type I Reverse Transcriptase Is Highly Mutagenic
Open Access
- 1 June 1996
- journal article
- Published by Elsevier
- Vol. 271 (26) , 15386-15392
- https://doi.org/10.1074/jbc.271.26.15386
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Reduced Frameshift Fidelity and Processivity of HIV-1 Reverse Transcriptase Mutants Containing Alanine Substitutions in Helix H of the Thumb SubdomainPublished by Elsevier ,1995
- Roadblocks and detours during DNA replication: Mechanisms of mutagenesis in mammalian cellsBioEssays, 1994
- Effect of Single DNA Lesions on in Vitro Replication with DNA Polymerase III Holoenzyme: Comparison with other PolymerasesJournal of Molecular Biology, 1994
- Effects of the anticancer drug cis-diamminedichloroplatinum(II) on the activities of calf thymus DNA polymerase .epsilon.Biochemistry, 1993
- Translesion DNA synthesis in the dihydrofolate reductase domain of UV-irradiated CHO cellsBiochemistry, 1992
- Replication inhibition and translesion synthesis on templates containing site- specifically placed cis-diamminedichloroplatinum(II) DNA adductsBiochemistry, 1992
- In vitro evidence that UV-induced frameshift and substitution mutations at T tracts are the result of misalignment-mediated replication past a specific thymine dimerBiochemistry, 1992
- Is Cisplatin a Human Carcinogen?JNCI Journal of the National Cancer Institute, 1992
- Fidelity of HIV-1 reverse transcriptase copying RNA in vitroBiochemistry, 1992
- A d(GpG)‐platinated decanucleotide duplex is kinkedEuropean Journal of Biochemistry, 1990